Sentences with phrase «developing mild cognitive impairment»

Depressive symptoms in elderly people are associated with an increased risk of developing mild cognitive impairment independently of vascular disease

In a 2010 article in the «Journal of Alzheimer's Disease,» researchers found that elderly people who consumed higher amounts of polyunsaturated and monounsaturated fats had a reduced likelihood of developing mild cognitive impairment, a precursor for dementia.

The researchers found that the study participants who were involved with social, craft, computer, or artistic activities had a reduced risk for developing mild cognitive impairment (MCI).

Researchers from the Mayo Clinic, publishing the results of their study in the Journal of Alzheimer's Disease, explain how people 70 and older who eat food high in carbohydrates have nearly four times the risk of developing mild cognitive impairment, and the danger is also present with a diet heavy in sugar.

People with sleep apnea, for example, a condition in which people repeatedly stop breathing at night, are at risk for developing mild cognitive impairment an average of 10 years earlier than people without the sleep disorder.

Not exact matches

But older people who develop Alzheimer's disease often first enter a stage known as mild cognitive impairment, which involves more serious problems with memory, language, thinking, and judgment.

Ongoing studies at Uppsala University in Sweden have shown that the chemical agent dubbed Pittsburgh Compound - B, or PIB, is a highly accurate marker of plaque buildup and that its abundance in the brain can predict whether patients with mild cognitive impairment will develop Alzheimer's — and when that decline will likely start.

People with mild cognitive impairment are at one - in - 10 risk of developing dementia within a year — and the risk is markedly higher among those with depression.

For instance, researchers at IBM Research in Haifa, Israel, are developing a five - minute screening tool that uses voice recordings and computer analysis to identify people with mild cognitive impairment, a precursor to dementia.

Researchers have developed a new cognitive test that can better determine whether memory impairments are due to very mild Alzheimer's disease or the normal aging process.

Their research technique of measuring electrical brain activity using an electroencephalogram (EEG) in these brain regions also predicted mild cognitive impairment (MCI), a condition that is likely to develop into Alzheimer's, with 80 per cent accuracy.

Researchers estimate that as many as 2.1 million patients with mild cognitive impairment could develop Alzheimer's dementia over a two - decade period while waiting for evaluation and treatment resources after approval of an Alzheimer's disease - modifying therapy by the federal Food and Drug Administration.

«Early detection of individuals at high risk of developing memory and thinking problems that we call mild cognitive impairment (MCI) is crucial because people with MCI are at a greater risk of developing dementia.

Of these, 52 were healthy, 48 had Alzheimer's disease and 48 had mild cognitive impairment (MCI), but were known to have developed Alzheimer's disease 2.5 to nine years later.

In a long - term, large - scale population - based study of individuals aged 55 years or older in the general population researchers found that those diagnosed with mild cognitive impairment (MCI) had a four-fold increased risk of developing dementia or Alzheimer's disease (AD) compared to cognitively healthy individuals.

A further analysis showed that 10 of these proteins could predict whether individuals with mild cognitive impairment would develop Alzheimer's within a year.

The academy's guideline authors developed the updated recommendations on mild cognitive impairment after reviewing all available studies.

Other research studies have reported a decline in social networks in people with Alzheimer's disease and Mild Cognitive Impairment (MCI), and previous literature has shown psychological well - being in older age to be associated with reduced risk of developing Alzheimer's dementia.

As a next step, the team is exploring whether older adults who have mild cognitive impairment (a condition that is likely to develop into Alzheimer's) could benefit from this strategy.

Dr. Ding's team enrolled older patients at high risk to develop Alzheimer's disease who have early signs of memory loss, or mild cognitive impairment (MCI).

During this time, 28 people developed Alzheimer's or mild cognitive impairment, thought to be the earliest noticeable sign of several types of dementia, including Alzheimer's disease.

A high percentage of patients with mild cognitive impairment (MCI) develop clinical dementia of the Alzheimer type (AD) within 1 year.

Researchers feel that it may develop first, then progress to mild cognitive impairment, and finally to Alzheimer's or a related dementia.

Sixteen percent of those over 70 y old have mild cognitive impairment and half of these develop Alzheimer's disease.

Studies carried out by a team of scientists concluded that the new blood tests were able to predict, with an 87 percent accuracy rate, whether patients suffering from MCI (Mild Cognitive Impairment) would develop Alzheimer's disease within a year.

We have developed genetic specific risk curves for patients with Mild Cognitive Impairment, a condition where the APOE e4 allele is associated with more rapid progression to AD and differential response to certain pharmacological treatments.

Every 66 seconds, a person develops the disease, and by the year 2060, about 15 million people in the United States will have Alzheimer's dementia or mild cognitive impairment.

Among those originally classified with mild cognitive impairment, baseline asymmetry was higher in those that progressed to Alzheimer's dementia and became even greater as symptoms developed.

During that time, 7.2 % of the men and 5.7 % of the women developed the mental - function problems known as mild cognitive impairment (MCI), with or without any accompanying memory loss.

The study focused on participants having mild cognitive impairment, due to the fact many were most likely going to develop Alzheimer's disease in just a few years.

Nobody who had mild cognitive impairment that later on developed Alzheimer's had initial caffeine levels above a critical level equal to having a few cups of coffee several hours before the blood sample was taken.

His group has developed a new approach to the treatment of Alzheimer's disease, and this approach has led to the discovery of subtypes of Alzheimer's disease, followed by the first description of reversal of symptoms in patients with mild cognitive impairment and early Alzheimer's disease, with the ReCODE (Reversal of Cognitive Decline) cognitive impairment and early Alzheimer's disease, with the ReCODE (Reversal of Cognitive Decline) Cognitive Decline) protocol.

They used mass spectrometry to analyse the blood plasma of 53 participants with mild cognitive impairment or Alzheimer's disease, including 18 who developed symptoms during the study, and 53 who remained cognitively healthy.

In terms of an actual diagnosis of mild cognitive impairment, however, the researchers only identified 37 people who developed that condition during the study, and the diets didn't have a significant effect on the risk for that diagnosis.